Clinical Oncology
Volume 20, Issue 9 , Pages 698-704 , November 2008

Evaluating Inter-fractional Changes in Volume and Position during Bladder Radiotherapy and the Effect of Volume Limitation as a Method of Reducing the Internal Margin of the Planning Target Volume

  • S.A. Mangar

      Affiliations

    • Department of Radiotherapy, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
    • Corresponding Author InformationAuthor for correspondence: S. A. Mangar, Hammersmith Hospital NHS Trust and Imperial College London, Garry Weston Centre, Du Cane Road, London W12 0HS, UK. Tel: +44-208-3170; Fax: +44-208-383-3054.
    • ,
  • N.R. Miller

      Affiliations

    • Department of Physics, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK
    • ,
  • V.S. Khoo

      Affiliations

    • Academic Radiotherapy Department, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK
    • ,
  • V. Hansen

      Affiliations

    • Academic Radiotherapy Department, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK
    • ,
  • H. McNair

      Affiliations

    • Academic Radiotherapy Department, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK
    • ,
  • A. Horwich

      Affiliations

    • Academic Radiotherapy Department, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK
    • ,
  • R.A. Huddart

      Affiliations

    • Academic Radiotherapy Department, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey, UK

Received 1 October 2007 ,Revised 24 July 2008 ,Accepted 28 July 2008.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108
  2. Gephardt GN, Baker PB. Interinstitutional comparison of bladder carcinoma surgical pathology report adequacy. A college of American pathologists Q-Probes study of 7234 bladder biopsies and curettings in 268 institutions. Arch Pathol Lab Med. 1995;119(8):681–685
  3. Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S. Delay and survival in bladder cancer. BJU Int. 2002;89(9):868–878
  4. Shipley WU, Kaufman DS, Tester WJ, Pilepich MV, Sandler HM. Overview of bladder cancer trials in the radiation therapy oncology group. Cancer. 2003;97(8 Suppl):2115–2119
  5. Mangar SA, Foo K, Norman A, et al. Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer. Clin Oncol (R Coll Radiol). 2006;18(6):466–473
  6. Muren LP, Redpath AT, McLaren D, et al. A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy. Radiother Oncol. 2006;80(1):98–105
  7. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 1999;353(9149):267–272
  8. Logue J, McBain CA. Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery. Clin Oncol (R Coll Radiol). 2005;17(7):508–513
  9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–310
  10. Hanna CL, Slade S, Mason MD, Burnet NG. Accuracy of patient positioning during radiotherapy for bladder and brain tumours. Clin Oncol (R Coll Radiol). 1999;11(2):93–98
  11. Meijer GJ, Rasch C, Remeijer P, Lebesque JV. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys. 2003;55(5):1277–1287
  12. Henry AM, Stratford J, McCarthy C, et al. X-ray volume imaging in bladder radiotherapy verification. Int J Radiat Oncol Biol Phys. 2006;64(4):1174–1178
  13. Logue JP, Sharrock CL, Cowan RA, Read G, Marrs J, Mott D. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 1998;41(4):929–931
  14. Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol. 2003;69(3):291–304
  15. Sur RK, Clinkard J, Jones WG, et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin Oncol (R Coll Radiol). 1993;5(1):30–33
  16. Harris SJ, Buchannan RB. An audit and evaluation of bladder movements during radical radiotherapy. Clin Oncol (R Coll Radiol). 1998;10(4):262–264
  17. Turner SL, Swindell R, Bowl N, et al. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys. 1997;39(2):355–360
  18. Fokdal L, Honore H, Hoyer M, Meldgaard P, Fode K, von der Maase H. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys. 2004;59(2):436–444
  19. Coombes GM, Millard RJ. The accuracy of portable ultrasound scanning in the measurement of residual urine volume. J Urol. 1994;152(6 Pt 1):2083–2085
  20. Dudley NJ, Kirkland M, Lovett J, Watson AR. Clinical agreement between automated and calculated ultrasound measurements of bladder volume. Br J Radiol. 2003;76(911):832–834
  21. Delcker A, Martin T, Tegeler C. Magnetic sensor data acquisition for three-dimensional ultrasound of the orbit. Eye. 1998;12(Pt 4):725–728
  22. Park SH, Choi BI, Han JK, et al. Volumetric tumor measurement using three-dimensional ultrasound: in vitro phantom study on measurement accuracy under various scanning conditions. Ultrasound Med Biol. 2004;30(1):27–34
  23. Strommen K, Stormark TA, Iversen BM, Matre K. Volume estimation of small phantoms and rat kidneys using three-dimensional ultrasonography and a position sensor. Ultrasound Med Biol. 2004;30(9):1109–1117

PII: S0936-6555(08)00320-8

doi: 10.1016/j.clon.2008.07.004

Clinical Oncology
Volume 20, Issue 9 , Pages 698-704 , November 2008

Article Tools

* Image Usage & Resolution